ZJYL
Income statement / Annual
Last year (2024), Jin Medical International Ltd.'s total revenue was $23.50 M,
an increase of 18.57% from the previous year.
In 2024, Jin Medical International Ltd.'s net income was $3.68 M.
See Jin Medical International Ltd.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
| Period Ended |
09/30/2024 |
09/30/2023 |
09/30/2022 |
09/30/2021 |
09/30/2020 |
09/30/2019 |
09/30/2018 |
| Operating Revenue |
$23.50 M |
$19.82 M |
$19.19 M |
$20.76 M |
$16.19 M |
$20.37 M |
$20.91 M |
| Cost of Revenue |
$14.00 M
|
$13.04 M
|
$12.99 M
|
$14.40 M
|
$10.70 M
|
$12.86 M
|
$13.25 M
|
| Gross Profit |
$9.50 M
|
$6.78 M
|
$6.20 M
|
$6.36 M
|
$5.50 M
|
$7.51 M
|
$7.66 M
|
| Gross Profit Ratio |
0.4
|
0.34
|
0.32
|
0.31
|
0.34
|
0.37
|
0.37
|
| Research and Development Expenses |
$1.50 M
|
$1.54 M
|
$1.89 M
|
$1.57 M
|
$1.26 M
|
$1.13 M
|
$1.20 M
|
| General & Administrative Expenses |
$3.26 M
|
$1.92 M
|
$1.77 M
|
$1.67 M
|
$1.50 M
|
$1.60 M
|
$1.72 M
|
| Selling & Marketing Expenses |
$1.10 M
|
$453.31 K
|
$402.01 K
|
$489.00 K
|
$385.09 K
|
$381.11 K
|
$513.10 K
|
| Selling, General & Administrative Expenses |
$4.37 M
|
$2.37 M
|
$2.18 M
|
$2.16 M
|
$1.88 M
|
$1.98 M
|
$2.23 M
|
| Other Expenses |
$0.00
|
$0.00
|
$244.12 K
|
$194.98 K
|
$123.28 K
|
$0.00
|
$0.00
|
| Operating Expenses |
$5.86 M
|
$3.92 M
|
$4.07 M
|
$3.73 M
|
$3.14 M
|
$3.11 M
|
$3.33 M
|
| Cost And Expenses |
$19.86 M
|
$16.95 M
|
$17.06 M
|
$18.13 M
|
$13.84 M
|
$15.96 M
|
$16.59 M
|
| Interest Income |
$466.52 K
|
$182.68 K
|
$181.61 K
|
$0.00
|
$0.00
|
$0.00
|
$25.24 K
|
| Interest Expense |
$0.00
|
$0.00
|
$0.00
|
$9.49 K
|
$112.40 K
|
$22.85 K
|
$0.00
|
| Depreciation & Amortization |
$346.13 K
|
$225.90 K
|
$357.27 K
|
$341.25 K
|
$324.93 K
|
$344.04 K
|
$368.26 K
|
| EBITDA |
$3.98 M |
$3.09 M |
$3.10 M |
$3.23 M |
$2.79 M |
$4.49 M |
$4.60 M |
| EBITDA Ratio |
0.17
|
0.16
|
0.16
|
0.16
|
0.17
|
0.22
|
0.22
|
| Operating Income Ratio |
0.15
|
0.14
|
0.11
|
0.13
|
0.15
|
0.22
|
0.2
|
| Total Other Income/Expenses Net |
$544.97 K
|
$354.68 K
|
$612.11 K
|
$248.85 K
|
-$1.52 K
|
-$276.61 K
|
$71.02 K
|
| Income Before Tax |
$4.18 M
|
$3.22 M
|
$2.74 M
|
$2.88 M
|
$2.35 M
|
$4.13 M
|
$4.30 M
|
| Income Before Tax Ratio |
0.18
|
0.16
|
0.14
|
0.14
|
0.15
|
0.2
|
0.21
|
| Income Tax Expense |
$763.88 K
|
$343.71 K
|
$36.11 K
|
$248.64 K
|
$147.15 K
|
$479.63 K
|
$616.88 K
|
| Net Income |
$3.68 M
|
$2.88 M
|
$2.71 M
|
$2.63 M
|
$2.21 M
|
$3.65 M
|
$3.68 M
|
| Net Income Ratio |
0.16
|
0.15
|
0.14
|
0.13
|
0.14
|
0.18
|
0.18
|
| EPS |
0.0235 |
0.0198 |
0.34 |
0.33 |
0.28 |
0.46 |
0.0092 |
| EPS Diluted |
0.0235 |
0.0198 |
0.34 |
0.33 |
0.28 |
0.46 |
0.0092 |
| Weighted Average Shares Out |
$156.48 M
|
$145.14 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$400.01 M
|
| Weighted Average Shares Out Diluted |
$156.47 M
|
$145.14 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$8.00 M
|
$400.00 M
|
| Link |
|
|
|
|
|
|
|
